Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2007-03-08

Clinical Trial Update: The Role of Calcipotriol as Radioprotector of Skin [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating calcipotriol as a radioprotective skin treatment in radiodermatitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Calcipotriol (calcipotriol)

Snippet

Sponsor: Rabin Medical Center | Conditions: Radiodermatitis | Phase 2 | Status: UNKNOWN